Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats.

Hargus G, Cooper O, Deleidi M, Levy A, Lee K, Marlow E, Yow A, Soldner F, Hockemeyer D, Hallett PJ, Osborn T, Jaenisch R, Isacson O.

Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15921-6. doi: 10.1073/pnas.1010209107. Epub 2010 Aug 23.

2.

Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions.

Swistowski A, Peng J, Liu Q, Mali P, Rao MS, Cheng L, Zeng X.

Stem Cells. 2010 Oct;28(10):1893-904. doi: 10.1002/stem.499.

3.

Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency.

Hu BY, Weick JP, Yu J, Ma LX, Zhang XQ, Thomson JA, Zhang SC.

Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4335-40. doi: 10.1073/pnas.0910012107. Epub 2010 Feb 16.

4.

Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence.

Feng Q, Lu SJ, Klimanskaya I, Gomes I, Kim D, Chung Y, Honig GR, Kim KS, Lanza R.

Stem Cells. 2010 Apr;28(4):704-12. doi: 10.1002/stem.321.

5.

A nonviral minicircle vector for deriving human iPS cells.

Jia F, Wilson KD, Sun N, Gupta DM, Huang M, Li Z, Panetta NJ, Chen ZY, Robbins RC, Kay MA, Longaker MT, Wu JC.

Nat Methods. 2010 Mar;7(3):197-9. doi: 10.1038/nmeth.1426. Epub 2010 Feb 7.

6.

Functional recapitulation of smooth muscle cells via induced pluripotent stem cells from human aortic smooth muscle cells.

Lee TH, Song SH, Kim KL, Yi JY, Shin GH, Kim JY, Kim J, Han YM, Lee SH, Lee SH, Shim SH, Suh W.

Circ Res. 2010 Jan 8;106(1):120-8. doi: 10.1161/CIRCRESAHA.109.207902. Epub 2009 Dec 3.

7.

A chemical platform for improved induction of human iPSCs.

Lin T, Ambasudhan R, Yuan X, Li W, Hilcove S, Abujarour R, Lin X, Hahm HS, Hao E, Hayek A, Ding S.

Nat Methods. 2009 Nov;6(11):805-8. doi: 10.1038/nmeth.1393. Epub 2009 Oct 18.

8.

Hippocampal development and neural stem cell maintenance require Sox2-dependent regulation of Shh.

Favaro R, Valotta M, Ferri AL, Latorre E, Mariani J, Giachino C, Lancini C, Tosetti V, Ottolenghi S, Taylor V, Nicolis SK.

Nat Neurosci. 2009 Oct;12(10):1248-56. doi: 10.1038/nn.2397. Epub 2009 Sep 6.

PMID:
19734891
9.

Direct reprogramming of human neural stem cells by OCT4.

Kim JB, Greber B, Araúzo-Bravo MJ, Meyer J, Park KI, Zaehres H, Schöler HR.

Nature. 2009 Oct 1;461(7264):649-3. doi: 10.1038/nature08436.

PMID:
19718018
10.

Variation in the safety of induced pluripotent stem cell lines.

Miura K, Okada Y, Aoi T, Okada A, Takahashi K, Okita K, Nakagawa M, Koyanagi M, Tanabe K, Ohnuki M, Ogawa D, Ikeda E, Okano H, Yamanaka S.

Nat Biotechnol. 2009 Aug;27(8):743-5. doi: 10.1038/nbt.1554. Epub 2009 Jul 9.

PMID:
19590502
11.

Regulation of neural specification from human embryonic stem cells by BMP and FGF.

LaVaute TM, Yoo YD, Pankratz MT, Weick JP, Gerstner JR, Zhang SC.

Stem Cells. 2009 Aug;27(8):1741-9. doi: 10.1002/stem.99.

12.

Generation of dopamine neurons with improved cell survival and phenotype maintenance using a degradation-resistant nurr1 mutant.

Jo AY, Kim MY, Lee HS, Rhee YH, Lee JE, Baek KH, Park CH, Koh HC, Shin I, Lee YS, Lee SH.

Stem Cells. 2009 Sep;27(9):2238-46. doi: 10.1002/stem.146.

13.

Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins.

Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS, Ko S, Yang E, Cha KY, Lanza R, Kim KS.

Cell Stem Cell. 2009 Jun 5;4(6):472-6. doi: 10.1016/j.stem.2009.05.005. Epub 2009 May 28. No abstract available.

14.

Cytoplasmic functions of the tumour suppressor p53.

Green DR, Kroemer G.

Nature. 2009 Apr 30;458(7242):1127-30. doi: 10.1038/nature07986. Review.

15.

Characterization of somatic Ca2+ clearance mechanisms in young and mature hippocampal granule cells.

Lee SH, Ho WK, Lee SH.

Cell Calcium. 2009 May;45(5):465-73. doi: 10.1016/j.ceca.2009.03.004. Epub 2009 Apr 10.

PMID:
19362367
16.

Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells.

Borowiak M, Maehr R, Chen S, Chen AE, Tang W, Fox JL, Schreiber SL, Melton DA.

Cell Stem Cell. 2009 Apr 3;4(4):348-58. doi: 10.1016/j.stem.2009.01.014.

17.

Human induced pluripotent stem cells free of vector and transgene sequences.

Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA.

Science. 2009 May 8;324(5928):797-801. doi: 10.1126/science.1172482. Epub 2009 Mar 26.

18.

Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors.

Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, Hargus G, Blak A, Cooper O, Mitalipova M, Isacson O, Jaenisch R.

Cell. 2009 Mar 6;136(5):964-77. doi: 10.1016/j.cell.2009.02.013.

19.

piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells.

Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hämäläinen R, Cowling R, Wang W, Liu P, Gertsenstein M, Kaji K, Sung HK, Nagy A.

Nature. 2009 Apr 9;458(7239):766-70. doi: 10.1038/nature07863. Epub 2009 Mar 1.

20.

Virus-free induction of pluripotency and subsequent excision of reprogramming factors.

Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K.

Nature. 2009 Apr 9;458(7239):771-5. doi: 10.1038/nature07864. Epub 2009 Mar 1.

Items per page

Supplemental Content

Write to the Help Desk